BRCA2 C-Terminal RAD51-Binding Domain Confers Resistance to DNA-Damaging Agents

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Apr 12

PMID 35409418

Authors

Zida Zhu

Taisuke Kitano

Masami Morimatsu

Arisa Tanaka

Ryo Morioka

Xianghui Lin

Koichi Orino

Yasunaga Yoshikawa

Affiliations

Soon will be listed here.

Abstract

Breast cancer type 2 susceptibility (BRCA2) protein is crucial for initiating DNA damage repair after chemotherapy with DNA interstrand crosslinking agents or X-ray irradiation, which induces DNA double-strand breaks. BRCA2 contains a C-terminal RAD51-binding domain (CTRBD) that interacts with RAD51 oligomer-containing nucleofilaments. In this study, we investigated CTRBD expression in cells exposed to X-ray irradiation and mitomycin C treatment. Surprisingly, BRCA2 CTRBD expression in HeLa cells increased their resistance to X-ray irradiation and mitomycin C. Under endogenous BRCA2 depletion using shRNA, the sensitivities of the BRCA2-depleted cells with and without the CTRBD did not significantly differ. Thus, the resistance to X-ray irradiation conferred by an exogenous CTRBD required endogenous BRCA2 expression. BRCA2 CTRBD-expressing cells demonstrated effective RAD51 foci formation and increased homologous recombination efficiency, but not nonhomologous end-joining efficiency. To the best of our knowledge, our study is the first to report the ability of the BRCA2 functional domain to confer resistance to X-ray irradiation and mitomycin C treatment by increased homologous recombination efficiency. Thus, this peptide may be useful for protecting cells against X-ray irradiation or chemotherapeutic agents.

References

Esashi F, Christ N, Gannon J, Liu Y, Hunt T, Jasin M . CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature. 2005; 434(7033):598-604. DOI: 10.1038/nature03404. View

Yoshikawa Y, Morimatsu M, Ochiai K, Ishiguro-Oonuma T, Morioka R, Okuda K . Identification of the core motif of the BRCA2 C-terminal RAD51-binding domain by comparing canine and human BRCA2. J Vet Med Sci. 2021; 83(5):759-766. PMC: 8182314. DOI: 10.1292/jvms.21-0006. View

Esashi F, Galkin V, Yu X, Egelman E, West S . Stabilization of RAD51 nucleoprotein filaments by the C-terminal region of BRCA2. Nat Struct Mol Biol. 2007; 14(6):468-74. DOI: 10.1038/nsmb1245. View

Maier P, Hartmann L, Wenz F, Herskind C . Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization. Int J Mol Sci. 2016; 17(1). PMC: 4730344. DOI: 10.3390/ijms17010102. View

Pierce A, Johnson R, Thompson L, Jasin M . XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev. 1999; 13(20):2633-8. PMC: 317094. DOI: 10.1101/gad.13.20.2633. View

van de Kamp G, Heemskerk T, Kanaar R, Essers J . DNA Double Strand Break Repair Pathways in Response to Different Types of Ionizing Radiation. Front Genet. 2021; 12:738230. PMC: 8514742. DOI: 10.3389/fgene.2021.738230. View

Bahassi E, Ovesen J, Riesenberg A, Bernstein W, Hasty P, Stambrook P . The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage. Oncogene. 2008; 27(28):3977-85. DOI: 10.1038/onc.2008.17. View

Michl J, Zimmer J, Tarsounas M . Interplay between Fanconi anemia and homologous recombination pathways in genome integrity. EMBO J. 2016; 35(9):909-23. PMC: 4865030. DOI: 10.15252/embj.201693860. View

Nomme J, Renodon-Corniere A, Asanomi Y, Sakaguchi K, Stasiak A, Stasiak A . Design of potent inhibitors of human RAD51 recombinase based on BRC motifs of BRCA2 protein: modeling and experimental validation of a chimera peptide. J Med Chem. 2010; 53(15):5782-91. PMC: 2917172. DOI: 10.1021/jm1002974. View

10.

Thompson L . Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: the molecular choreography. Mutat Res. 2012; 751(2):158-246. DOI: 10.1016/j.mrrev.2012.06.002. View

11.

Yoshikawa Y, Ochiai K, Morimatsu M, Suzuki Y, Wada S, Taoda T . Effects of the missense mutations in canine BRCA2 on BRC repeat 3 functions and comparative analyses between canine and human BRC repeat 3. PLoS One. 2012; 7(10):e45833. PMC: 3470543. DOI: 10.1371/journal.pone.0045833. View

12.

Morimoto S, Tsuda M, Bunch H, Sasanuma H, Austin C, Takeda S . Type II DNA Topoisomerases Cause Spontaneous Double-Strand Breaks in Genomic DNA. Genes (Basel). 2019; 10(11). PMC: 6895833. DOI: 10.3390/genes10110868. View

13.

Bennardo N, Cheng A, Huang N, Stark J . Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet. 2008; 4(6):e1000110. PMC: 2430616. DOI: 10.1371/journal.pgen.1000110. View

14.

Andreassen P, Seo J, Wiek C, Hanenberg H . Understanding BRCA2 Function as a Tumor Suppressor Based on Domain-Specific Activities in DNA Damage Responses. Genes (Basel). 2021; 12(7). PMC: 8307705. DOI: 10.3390/genes12071034. View

15.

Wang A, Kim T, Wagner J, Conti B, Lach F, Huang A . A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous Recombination. Mol Cell. 2015; 59(3):478-90. PMC: 4529964. DOI: 10.1016/j.molcel.2015.07.009. View

16.

Liang C, Zhan B, Yoshikawa Y, Haas W, Gygi S, Cohn M . UHRF1 is a sensor for DNA interstrand crosslinks and recruits FANCD2 to initiate the Fanconi anemia pathway. Cell Rep. 2015; 10(12):1947-56. PMC: 4386029. DOI: 10.1016/j.celrep.2015.02.053. View

17.

Prakash R, Zhang Y, Feng W, Jasin M . Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins. Cold Spring Harb Perspect Biol. 2015; 7(4):a016600. PMC: 4382744. DOI: 10.1101/cshperspect.a016600. View

18.

Carreira A, Kowalczykowski S . Two classes of BRC repeats in BRCA2 promote RAD51 nucleoprotein filament function by distinct mechanisms. Proc Natl Acad Sci U S A. 2011; 108(26):10448-53. PMC: 3127913. DOI: 10.1073/pnas.1106971108. View

19.

Richardson C, Moynahan M, Jasin M . Double-strand break repair by interchromosomal recombination: suppression of chromosomal translocations. Genes Dev. 1998; 12(24):3831-42. PMC: 317271. DOI: 10.1101/gad.12.24.3831. View

20.

Huang R, Zhou P . DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther. 2020; 5(1):60. PMC: 7192953. DOI: 10.1038/s41392-020-0150-x. View